These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2322298)

  • 1. The pharmacokinetics of polymer-bound adriamycin.
    Seymour LW; Ulbrich K; Strohalm J; Kopecek J; Duncan R
    Biochem Pharmacol; 1990 Mar; 39(6):1125-31. PubMed ID: 2322298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.
    Seymour LW; Ulbrich K; Wedge SR; Hume IC; Strohalm J; Duncan R
    Br J Cancer; 1991 Jun; 63(6):859-66. PubMed ID: 1648946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.
    Omelyanenko V; Kopecková P; Gentry C; Kopecek J
    J Control Release; 1998 Apr; 53(1-3):25-37. PubMed ID: 9741911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination.
    Satchi R; Connors TA; Duncan R
    Br J Cancer; 2001 Sep; 85(7):1070-6. PubMed ID: 11592781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments.
    Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J
    Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biorecognition of HPMA copolymer-adriamycin conjugates by lymphocytes mediated by synthetic receptor binding epitopes.
    Omelyanenko V; Kopecková P; Prakash RK; Ebert CD; Kopecek J
    Pharm Res; 1999 Jul; 16(7):1010-9. PubMed ID: 10450924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts.
    Shiah JJ; Sun Y; Peterson CM; Kopecek J
    J Control Release; 1999 Aug; 61(1-2):145-57. PubMed ID: 10469911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanoma.
    O'Hare KB; Duncan R; Strohalm J; Ulbrich K; Kopeckova P
    J Drug Target; 1993; 1(3):217-29. PubMed ID: 8069563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymer-doxorubicin (PK1).
    Duncan R; Coatsworth JK; Burtles S
    Hum Exp Toxicol; 1998 Feb; 17(2):93-104. PubMed ID: 9506260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line.
    Kunath K; Kopecková P; Minko T; Kopecek J
    Eur J Pharm Biopharm; 2000 Jan; 49(1):11-5. PubMed ID: 10613922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells.
    Minko T; Kopecková P; Kopecek J
    Pharm Res; 1999 Jul; 16(7):986-96. PubMed ID: 10450921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: and experimental study in the rat.
    Yeung TK; Hopewell JW; Simmonds RH; Seymour LW; Duncan R; Bellini O; Grandi M; Spreafico F; Strohalm J; Ulbrich K
    Cancer Chemother Pharmacol; 1991; 29(2):105-11. PubMed ID: 1760851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of the cardiotoxicity of PK2: a novel HPMA copolymer-doxorubicin-galactosamine conjugate antitumour agent.
    Hopewel JW; Duncan R; Wilding D; Chakrabarti K
    Hum Exp Toxicol; 2001 Sep; 20(9):461-70. PubMed ID: 11776408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the toxic effects of magnetic targeting adriamycin-carboxymethyldextran magnetic nanoparticles].
    Shi K; Li C; He B
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):219-21. PubMed ID: 12856583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.
    Duncan R; Kopecková P; Strohalm J; Hume IC; Lloyd JB; Kopecek J
    Br J Cancer; 1988 Feb; 57(2):147-56. PubMed ID: 3358905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pharmacological and biological properties of HPMA copolymer-pirarubicin conjugates: A single-chain copolymer conjugate and its biodegradable tandem-diblock copolymer conjugate.
    Etrych T; Tsukigawa K; Nakamura H; Chytil P; Fang J; Ulbrich K; Otagiri M; Maeda H
    Eur J Pharm Sci; 2017 Aug; 106():10-19. PubMed ID: 28528285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel α
    Wang F; Li L; Sun W; Li L; Liu Y; Huang Y; Zhou Z
    J Drug Target; 2018 Mar; 26(3):231-241. PubMed ID: 28792244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.
    Vasey PA; Kaye SB; Morrison R; Twelves C; Wilson P; Duncan R; Thomson AH; Murray LS; Hilditch TE; Murray T; Burtles S; Fraier D; Frigerio E; Cassidy J
    Clin Cancer Res; 1999 Jan; 5(1):83-94. PubMed ID: 9918206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro.
    Lu JM; Peterson CM; Guo-Shiah J; Gu ZW; Peterson CA; Straight RC; Kopecek J
    Int J Oncol; 1999 Jul; 15(1):5-16. PubMed ID: 10375588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia.
    Tomalova B; Sirova M; Rossmann P; Pola R; Strohalm J; Chytil P; Cerny V; Tomala J; Kabesova M; Rihova B; Ulbrich K; Etrych T; Kovar M
    J Control Release; 2016 Feb; 223():1-10. PubMed ID: 26708020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.